Alexander Korenberg

Alexander,  IP Strategist & Counsel in our Patents team is globally recognised for his expertise in strategic IP value creation and high-stakes contentious proceedings. He has been described as the "go-to expert in the UK for any AI-related matters" and is particularly sought after by AI companies of all sizes to protect and defend their inventions.

Alexander is a European and UK Patent Attorney and a UPC Representative and brings over two decades of experience maximising and defending IP value. He advises technology leaders, scaling enterprises, and research spin-outs on aligning intellectual property with core business objectives. As a trusted adviser, he works with multinational corporations to grow and defend their portfolios over multiple market cycles and to clear the way for their products. His practice centres on contentious proceedings before the European Patent Office, high-value freedom-to-operate planning, and developing portfolios that capture and defend commercial value.

With an academic background at the intersection of physics, computer science, and neuroscience, including a PhD, he is widely trusted to protect complex AI, machine learning, and data science innovation. A key focal point of his practice applies this expertise to healthcare, notably in drug discovery, digital health, and medical devices.

Alexander has been consistently ranked amongst the top 300 IP strategists globally by Intellectual Asset Management Magazine for over a decade and is recognised as an IAM 1000 Global Leader for patents. His recognition is based directly on strong relationships with his clients, who consistently describe him as sharp, technologically savvy, business-focused, and easy to work with. Alexander frequently shares his knowledge and experience as an invited speaker on patenting AI technologies and IP considerations in AI-driven drug discovery.

Key Experience

• Successfully represented innovative multinational technology corporations in multi-party opposition and appeal proceedings before the European Patent Office, defending critical commercial rights and revoking blocking competitor patents.
• Cleared the way for a new approach to personalised cancer vaccines by comprehensively revoking a patent that risked blocking the entire field. Having been asked to take over representation at a late stage of the proceedings, he identified numerous new conclusive lines of attack, providing reassurance about the outcome beyond the first-instance proceedings.
• Advised a high-growth spin-out on its global patent architecture for point-of-care diagnostic hardware and software, stress-testing the portfolio to clear significant venture and debt financing due diligence.
• Advised numerous start-ups applying AI to fields ranging from additive manufacturing to drug discovery on their IP strategy and commercial value capture, acting as virtual in-house counsel.

Career History

IP Strategist & Counsel, Mishcon de Reya LLP
Partner, Kilburn & Strode LLP
University College London (UCL), PhD Computational Neuroscience
Imperial College London, MSci Physics

Articles and Publications

• Intellectual Property Strategy: A Practical Guide to IP Management (Globe Law and Business) – Contributing Editor (with Stephen Robertson) and chapter author: "Conflicting patent rights and operational freedom"
• LexisNexis Practice Note: Artificial intelligence and machine learning—an introduction to the technology and its IP implications
• EPO Oppositions and Appeals: Strategic Relevance in the UPC Era